Pennant Group, Inc. (PNTG) · Nov 4, 2026 · Earnings
Miss — Adjusted EPS $0.35 vs ~$0.357 consensus
Pennant Group’s Q3 earnings show accelerating home-health and hospice growth and a revenue beat, but adjusted EPS narrowly missed consensus as integration costs lingered.
Pennant is in the scale-up phase of a post-acute healthcare roll-up, integrating the large UnitedHealth/Amedisys asset purchase while expanding home health, hospice, and senior living operations. Its prior setup already called for strong 2026 growth, with management guiding to $1.34–$1.41 of adjusted EPS and $1.171–$1.190 billion of revenue for the full year.
The core operating engine is still outperforming: Q3 revenue reached $302.3 million, above the roughly $299.3 million published consensus, while home health and hospice revenue grew 38.2% year over year. The strongest evidence is operational rather than accounting-driven: total home health admissions rose 39.4%, hospice average daily census rose 34.6%, and the home health and hospice segment’s adjusted EBITDAR increased 42.3%. 〔0〕
| Q3 2026 | Q3 2025 | Consensus | |
|---|---|---|---|
| Revenue (Income Statement) | $302.3M (+32.0%) | $229.0M | ~$299.3M |
| GAAP diluted EPS (Income Statement) | $0.26 (+52.9%) | $0.17 | |
| Adjusted diluted EPS (Non-GAAP reconciliation) | $0.35 (+16.7%) | $0.30 | ~$0.357 |
| Adjusted EBITDA (EBITDA reconciliation) | $24.7M (+42.4%) | $17.3M | |
| Operating cash flow, nine months (Cash Flow statement) | $43.5M (+59.3%) | $27.3M |
The miss is narrow and sits in earnings per share, not demand: adjusted diluted EPS of $0.35 was slightly below the approximately $0.357 consensus, even as revenue exceeded expectations. The gap reflects a heavier cost structure during expansion, including $1.55 million of transition-services costs tied to the UnitedHealth transaction and higher interest expense.
Same-store results show the acquired growth is not the whole story: same-store home health admissions rose 8.0%, Medicare home health admissions rose 12.0%, and same-store hospice census increased 13.0%. That supports management’s claim that its operating model is improving existing locations while absorbing acquisitions. 〔1〕
Senior living remains the softer piece: revenue increased 12.6%, but total occupancy fell 250 basis points to 78.4%; same-store occupancy declined 60 basis points to 81.2%. Higher revenue per occupied unit partly offset the occupancy pressure, but this segment is contributing less operating momentum than home health and hospice.
The outlook was maintained, not upgraded: management said the quarter was consistent with full-year guidance. That makes the result broadly on track operationally, but it does not create a new upside signal versus the standing expectation. The company is executing well against its acquisition-led growth plan, yet the slight EPS miss and continuing transition costs keep this from being a clean earnings beat. 〔2〕
Bottom line: Pennant’s underlying healthcare demand and same-store execution remain strong, and revenue beat expectations. But because adjusted EPS came in just below consensus and guidance was merely reaffirmed, this is a mixed quarter rather than a clean beat—modestly advancing the business story, not rewriting it.
Q3 results webcast, November 5, 2026
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!